Total Payments
$63,459
2024 Payments
$2,964
Companies
55
Transactions
1,047
Medicare Patients
3,857
Medicare Billing
$433,726
Payment Breakdown by Category
Other$33,250 (52.4%)
Food & Beverage$17,383 (27.4%)
Consulting$9,000 (14.2%)
Travel$3,722 (5.9%)
Education$103.13 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $33,250 | 17 | 52.4% |
| Food and Beverage | $17,383 | 1,002 | 27.4% |
| Consulting Fee | $9,000 | 3 | 14.2% |
| Travel and Lodging | $3,722 | 19 | 5.9% |
| Education | $103.13 | 3 | 0.2% |
| Unspecified | $0 | 3 | 0.0% |
Payments by Type
General
$63,459
1,044 transactions
Ownership
$0
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NESTLE HEALTHCARE NUTRITION INC. | $26,795 | 32 | $0 (2023) |
| US ENDOSCOPY | $9,883 | 6 | $0 (2022) |
| Allergan Inc. | $9,592 | 29 | $0 (2019) |
| ABBVIE INC. | $4,838 | 343 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $1,451 | 18 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,204 | 90 | $0 (2024) |
| Gilead Sciences, Inc. | $1,122 | 54 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,074 | 84 | $0 (2024) |
| Janssen Biotech, Inc. | $1,005 | 77 | $0 (2024) |
| Celgene Corporation | $896.72 | 56 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,964 | 182 | ABBVIE INC. ($758.40) |
| 2023 | $2,006 | 141 | AbbVie Inc. ($822.67) |
| 2022 | $12,438 | 166 | Nestle HealthCare Nutrition Inc. ($7,182) |
| 2021 | $28,850 | 177 | Nestle HealthCare Nutrition Inc. ($19,595) |
| 2020 | $2,188 | 97 | Medtronic USA, Inc. ($788.98) |
| 2019 | $11,065 | 110 | Allergan Inc. ($9,382) |
| 2018 | $1,576 | 81 | BOSTON SCIENTIFIC CORPORATION ($455.81) |
| 2017 | $2,372 | 93 | BOSTON SCIENTIFIC CORPORATION ($698.61) |
All Payment Transactions
1,047 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Immunology | ||||||
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.32 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $0.95 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $0.67 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Immunology | ||||||
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $0.94 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug), PLENVU | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Gastroenterology | ||||||
| 12/11/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $8.06 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $2.58 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/06/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $30.44 | General |
| 12/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Gastroenterology | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $2.01 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Immunology | ||||||
| 11/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $3.13 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $2.23 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $0.65 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 964 | 1,394 | $628,278 | $114,589 |
| 2022 | 24 | 906 | 1,031 | $544,965 | $103,187 |
| 2021 | 23 | 1,017 | 1,302 | $395,435 | $111,451 |
| 2020 | 27 | 970 | 1,199 | $354,483 | $104,499 |
Total Patients
3,857
Total Services
4,926
Medicare Billing
$433,726
Procedure Codes
102
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 119 | 150 | $32,550 | $13,265 | 40.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 68 | 70 | $74,690 | $12,254 | 16.4% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 31 | 267 | $40,584 | $9,611 | 23.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 85 | 88 | $24,464 | $8,982 | 36.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 30 | 148 | $14,800 | $7,097 | 48.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 68 | 68 | $22,576 | $6,957 | 30.8% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2023 | 31 | 36 | $55,332 | $6,650 | 12.0% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope | Facility | 2023 | 17 | 17 | $33,235 | $6,086 | 18.3% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 46 | 53 | $37,153 | $5,304 | 14.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 115 | 124 | $75,296 | $4,714 | 6.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 33 | 34 | $13,974 | $4,618 | 33.0% |
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 16 | 20 | $22,200 | $4,085 | 18.4% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 25 | 25 | $23,875 | $3,653 | 15.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 57 | $8,436 | $3,451 | 40.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 41 | 41 | $8,979 | $3,027 | 33.7% |
| 43246 | Insertion of stomach tube using a flexible endoscope | Facility | 2023 | 14 | 15 | $12,660 | $2,343 | 18.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 38 | 38 | $32,186 | $2,125 | 6.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $10,934 | $2,004 | 18.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 22 | 22 | $11,396 | $1,910 | 16.8% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $9,328 | $1,608 | 17.2% |
| 45398 | Banding of hemorrhoids using a flexible endoscope (colonoscope) | Facility | 2023 | 12 | 12 | $14,400 | $1,367 | 9.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 14 | $2,968 | $1,306 | 44.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 14 | 14 | $3,038 | $1,007 | 33.1% |
| 74328 | Review by radiologist of image from tube placement into bile duct using an endoscope | Facility | 2023 | 32 | 36 | $13,044 | $627.20 | 4.8% |
| 43262 | Incision of pancreatic outlet using a flexible endoscope | Facility | 2023 | 19 | 20 | $30,180 | $541.20 | 1.8% |
About Dr. Edward Dauterive, M.D
Dr. Edward Dauterive, M.D is a Gastroenterology healthcare provider based in Slidell, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/19/2010. The National Provider Identifier (NPI) number assigned to this provider is 1720302730.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edward Dauterive, M.D has received a total of $63,459 in payments from pharmaceutical and medical device companies, with $2,964 received in 2024. These payments were reported across 1,047 transactions from 55 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($33,250).
As a Medicare-enrolled provider, Dauterive has provided services to 3,857 Medicare beneficiaries, totaling 4,926 services with total Medicare billing of $433,726. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Slidell, LA
- Active Since 03/19/2010
- Last Updated 12/13/2016
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1720302730
Products in Payments
- ZENPEP (Drug) $36,038
- Padlock Clip (Device) $5,037
- RINVOQ (Biological) $990.10
- ZEPOSIA (Drug) $882.29
- ENTYVIO (Biological) $831.09
- HUMIRA (Biological) $826.07
- LINZESS (Drug) $783.47
- XIFAXAN (Drug) $758.56
- INTERSTIM (Device) $660.44
- STELARA (Biological) $657.50
- GENERAL - BILIARY DEVICES (Device) $604.36
- Humira (Biological) $520.36
- XELJANZ (Drug) $464.49
- SKYRIZI (Biological) $439.45
- SPYGLASS (Device) $428.07
- DIFICID (Drug) $373.22
- Cook Medical Endoscopic Ultrasound (Device) $370.55
- OCALIVA (Drug) $319.12
- DUPIXENT (Biological) $284.10
- TRULANCE (Drug) $282.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Slidell
Anthony Albright, M.d, M.D
Gastroenterology — Payments: $22,879
Gastroenterology $22,879
Veronica Dugan, M.d, M.D
Gastroenterology — Payments: $18,530
Gastroenterology $18,530
Timothy Trainor, M.d, M.D
Gastroenterology — Payments: $14,155
Gastroenterology $14,155
Kimberly Dalmau, M.d, M.D
Gastroenterology — Payments: $2,310
Gastroenterology $2,310
Dasarathy Srinivas, M.d, M.D
Gastroenterology — Payments: $1,456
Gastroenterology $1,456
Malcolm Andry, M.d, M.D
Gastroenterology — Payments: $205.02
Gastroenterology $205.02